ARCHIVES

FDA to refer false statements by regulated companies to SEC.

This article is from The Cancer Letter archive.

Vol. 30 No. 09 | February 27, 2004

Download PDF Visit The Full Archive

Related Articles

Six Grants Awarded, Five More On Way For Elderly Research

May 4, 1984

Obey Convinces House Hew Subcommittee to Cut $17 Million Control, Give It To Bioassays

June 1, 1979

HHS News: Shalala To Form Genetic Testing Advisory Committee

August 14, 1998

In brief: ring appointed Associate Dean At UCSF; Univ. of Utah Forms Cell Signaling Center

August 1, 1997

DCT Faces Hard Choices, Clinical Group Need Re-Examination, Chabner tells BSC

November 12, 1982

ACS Urged To Put More Resources Into Psychosocial Research

May 8, 1981